Akebia Therapeutics, Inc. (AKBA)

1.62 -0.04 (-2.41%) USD  |  NASDAQ  |  Dec 29, 16:00
1.61 -0.01 (-0.62%) After-Hours: 20:00
More

Akebia Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade